在固体瘤中与瘤微环境相互作用的CAR-T细胞技术
Chelsea Alice Taylor1, Maya Glover1, John Maher1,2,3
1Leucid Bio Ltd, Guy's Hospital, London, UK.
Expert review of clinical immunology
|July 18, 2024
概括
化学抗原受体 (CAR) T细胞疗法对血液癌症有希望,但在固体瘤中面临挑战. 使用先进策略的工程CAR T细胞可以提高它们对固体瘤的有效性.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) T细胞对血液恶性瘤有效.
- 卡尔T细胞治疗在治疗固体瘤方面取得了有限的成功.
- 挑战包括目标选择,T细胞透和瘤微环境.
研究的目的:
- 审查CAR T细胞技术对固体瘤的最新进展.
- 为解决CAR T细胞治疗固体瘤的挑战.
- 探索改善CAR T细胞在固体瘤中的疗效的策略.
主要方法:
- 从1987年到现在的PubMed数据库的文献综述.
- 专注于详细研究CAR T细胞工程用于固体瘤的研究.
- 对瘤招募,透和克服免疫抑制的策略的分析.
主要成果:
- 汽车T细胞可以通过"装甲"策略进行设计.
- 这些策略增强了对固体瘤的贩运和透.
- 抑制免疫检查点的逆转是一个关键的进步.
结论:
- 卡尔T细胞疗法对固体瘤有潜力,需要进一步的工程.
- 先进的策略对于克服固体瘤特异性挑战至关重要.
- 未来的研究应该专注于优化CAR T细胞用于固体瘤微环境.
相关概念视频
Tumor Immunotherapy
504
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


